European Union Approves Corn Stack with Herculex RW and Roundup Ready 2 Traits for Food, Feed, Import and ...(progress. Dow AgroSciences provides inn...)

Date:11/2/2009

progress. Dow AgroSciences provides innovative technologies for crop protection, pest and vegetation management, seeds, traits, and agricultural biotechnology to serve the world's growing population. Dow AgroSciences will market this technology in its soybean seed brands including Mycogen, Brodbeck, Dairyland, and Renze. Global sales for Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company, are $4.5 billion. Learn more at www.dowagro.com.

Pioneer Hi-Bred, a DuPont business, is the world’s leading source of customized solutions for farmers, livestock producers and grain and oilseed processors. With headquarters in Des Moines, Iowa, Pioneer provides access to advanced plant genetics in nearly 70 countries.

DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

Herculex® RW Rootworm Protection technology by Dow AgroSciences and Pioneer Hi-Bred, a DuPont business.

Herculex® and the HX logo are registered trademarks of Dow AgroSciences LLC.

Roundup Ready® is a registered trademark used under license from Monsanto Company.

Contacts:   

DuPont
Doyle Karr
515-270-3428

Dow AgroSciences LLC
Garry Hamlin
317-337-4799

###

Read the full story at http://www.prweb.com/releases/DuPont/Herculex_RW/prweb3148194.htm.

'/>"/>

Source: PRWeb Copyright©2009 Vocus, Inc. All rights reserved

0 GOOD

Page: 1 2 3
Related biology technology :

1. Shire Secures European Wide Label Extension for FOSRENOL(R) in Chronic Kidney Disease
2. Regenerons Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
3. Pulmo BioTech Inc. Announces Cash Details of its Previously Announced Letter of Intent Intended to Bring its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) to the European Market
4. SpectraScience Engages European Contract Research Organization to Manage Clinical Trials
5. Ipsen and Debiopharm Group Announce That Decapeptyl(R)(triptorelin embonate) 6-month Successfully Completes the European Decentralised Procedure for the Treatment of Locally Advanced or Metastatic Prostate Cancer
6. TargetEx Leads the European Cancer Research Consortium
7. Intarcia Therapeutics, Inc. Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabetes Conference
8. InteKrin Therapeutics Presents Positive INT131 Phase 2b Results at the 45th Annual European Association for the Study of Diabetes Meeting
9. Global Med Technologies(R) Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product
10. INV102 Asthma Product Discussed at the European Respiratory Society
11. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting